We studied the control of dorsal raphe (DR) serotonergic neurons by dopaminergic transmission in rat brain using microdialysis and single unit extracellular recordings. Apomorphine (0.5±3.0 mg/kg s.c.) and quinpirole (0.5 mg/kg s.c.) increased serotonin (5-HT) output in the DR and (only apomorphine) in striatum. These effects were antagonized by 0.3 mg/kg s.c. SCH 23390 (in DR and striatum) and 1 mg/kg s.c. raclopride (in DR). 5-HT 1A receptor blockade potentiated the 5-HT increase produced by apomorphine in the DR. Apomorphine (50±400 mg/kg i.v.) increased the ®ring rate of most 5-HT neurons, an effect prevented by SCH 23390 and raclopride. Quinpirole (40±160 mg/kg i.v.) also enhanced the ®ring rate of 5-HT neurons. When applied in the DR, neither drug increased the 5-HT output in the DR or striatum.
The serotonergic (5-hydroxytryptamine, 5-HT) and dopaminergic systems interact in many ways in mammalian brain. The serotonergic transmission facilitates the release of striatal dopamine (DA), although the receptor subtype(s) involved remain to be fully clari®ed (Blandina et al. 1988; Chen et al. 1991; Benloucif et al. 1993; Galloway et al. 1993; Bonhomme et al. 1995; de Deurwaerde Áre et al. 1995; . There is also anatomical and functional evidence of an interaction between the serotonergic dorsal raphe nucleus (DR) and the dopaminergic mesencephalic nuclei (Azmitia and Segal 1978; Van der Kooy and Hattori 1980; Stern et al. 1981; Ho Èkfelt et al. 1984; Kale Ân et al. 1988; Peyron et al. 1995) . The pars reticulata of substantia nigra (SN), containing the dendrites of nigrostriatal dopaminergic neurons, receives a very dense serotonergic input from the DR (Fallon and Loughlin 1995) which modulates the activity of striatonigral GABAergic afferents (Stanford and Lacey 1996) . On the other hand, the electrical stimulation of the SN suppressed the ®ring activity of DR serotonergic neurons (Stern et al. 1981) . At postsynaptic level, the striatum is a major area for the convergence of ascending dopaminergic and serotonergic inputs from the midbrain, together with glutamatergic inputs from the cerebral cortex and thalamic nuclei (Azmitia and Segal 1978; Bjo Èrklund and Lindvall 1984; Graybiel 1990) .
Serotonergic agents modify the activity of dopaminergic cell units (Ugedo et al. 1989; Nedergaard et al. 1991; Arborelius et al. 1993 Arborelius et al. , 1994 Lejeune and Millan 1998) and the microinfusion of 5-HT in the ventral tegmental area increased DA release in N. accumbens (Guan and McBride 1989) . Conversely, the stimulation of dopaminergic receptors by apomorphine increased the 5-HT output in the DR and forebrain (Ferre Â et al. 1994; Matsumoto et al. 1996; Mendlin et al. 1998 ) and the local application of l-DOPA in the SN enhanced the local 5-HT output (Thorre Â et al. 1998 ). These observations suggest that dopaminergic and serotonergic systems modulate each other to act in a co-operative manner in the forebrain. However, the localization of the DA receptors involved in the apomorphine-induced increase in 5-HT output is not known. Mendlin et al. (1998 Mendlin et al. ( , 1999 blocked the striatal increase in 5-HT output induced by behavioural activation and by the systemic apomorphine administration with local application of the DA D 2 antagonist raclopride. However, the local application of the DA D2-like agonist quinpirole in a wide range of concentrations did not modify the striatal 5-HT output (Ferre Â et al. 1994; Abella Ân et al. 2000b) .
To further study the dopaminergic control of 5-HT neurons of the DR, we have conducted the present in vivo study using single unit extracellular recordings of 5-HT neurons in the DR and intracerebral microdialysis in the DR and striatum. This has been complemented by an in situ hybridization analysis to examine the presence of cells expressing DA D 2 receptors in the DR and neighbouring areas. The results support the proposal that DA D2-like receptors outside the DR increase the activity of DR 5-HT neurons. These are possibly located (among other areas) in the SN and the periaqueductal grey matter (PAG).
Materials and methods

Animals
Male albino rats weighing 280±320 g (Iffa Credo, Lyon, France) and 200±300 g (University of the Basque Country) were used in microdialysis and electrophysiological experiments, respectively. Animals were kept in a controlled environment (12-h light-dark cycle and 22^28C). Food and water were provided ad libitum. Animal care followed the European Union regulations (OJ of EC L358/1 18/12/1986).
Drugs and reagents 5-HT oxalate, 8-OH-DPAT (1/±)-8-hydroxy-2-(di-N-propylamino)-tetralin, apomorphine´HCl, quinpirole´HCl, SCH 23390 [R(1)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine´HCl] tetrodotoxin (TTX), veratridine and WAY 100635 N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)-cyclohexanecarboxamide´3HCl were from RBI (Natick, MA, USA). Citalopram´HBr and raclopride were kindly provided by Lundbeck A/S (Copenhagen-Valby, Denmark) and Astra (Soderta Èlje, Sweden), respectively. Other materials and reagents were from local commercial sources. Drugs were dissolved in saline and injected s.c. (microdialysis experiments) or i.v. (single unit recordings). Doses are expressed as free bases. Control rats received vehicle. For the assessment of local effects in microdialysis experiments, the drugs were dissolved in the perfusion¯uid and applied by reverse dialysis. Concentrated solutions (1 mm; pH adjusted to 6.5±7 with NaHCO 3 when necessary) were stored frozen (2 808C) and working solutions were prepared daily by dilution.
Surgery and microdialysis procedures
An updated description of the microdialysis procedures used can be found in Adell and Artigas (1998) . Brie¯y, anaesthetized rats (sodium pentobarbital, 60 mg/kg i.p.) were stereotaxically implanted with concentric microdialysis probes equipped with a Cuprophan membrane in the DR (AP 2 7.8, L 2 3.1, DV27.5, with an angle of 308; probe tip 1.5 mm), dorsal striatum (AP 1 0.2, L 2 3.0, DV28.0; probe tip 4.0 mm) or the SN (AP 2 5.3, L 1 2.4, DV28.4; probe tip 1.5 mm) (coordinates in mm from bregma and duramater; Paxinos and Watson 1986) . At 20±24 h after surgery, probes were perfused at 0.25 mL/min with arti®cial cerebrospinal¯uid (125 mm NaCl, 2.5 mm KCl, 1.26 mm CaCl 2 and 1.18 mm MgCl 2 ). After a 1-h stabilization period, four fractions were collected to obtain basal values before local or systemic administration of drugs. Successive 20-min (5 mL) dialysate samples were collected. Unless otherwise indicated, the perfusion¯uid was supplemented with 1 mm of the selective 5-HT reuptake inhibitor citalopram. This enhanced the detectability of 5-HT in dialysate samples and enabled to measure drug effects on 5-HT release, because in absence of an uptake blocker the 5-HT collected in brain dialysates is representative of the equilibrium between release and reuptake (Jackson and Abercrombie 1992; Romero et al. 1998) . To avoid the enhancement of 5-HT release in the DR induced by handling and injection procedures (Adell et al. 1997) , the rats were gently manipulated before performing the microdialysis experiments. To examine the role of dopaminergic receptors in the DR (or SN) on the 5-HT output in striatum (or DR), groups of rats were implanted with two probes, as described above. Drugs (apomorphine, quinpirole or TTX) were dissolved in the dialysis¯uid, perfused through the probe located in the DR or SN and their effects on local and distal 5-HT output were examined. Control rats were perfused for the whole experiment with arti®cial CSF but sham changes of the perfusion syringes were equally done.
At the end of the experiments, rats were killed by an overdose of sodium pentobarbital. The placement of the dialysis probes was examined by perfusion of Fast Green dye and visual inspection of the probe track after cutting the brain at the appropriate levels. The data of animals with the probes outside the structures of interest were not included in the calculations. The concentration of 5-HT in dialysate samples was determined by HPLC method, as described (Adell and Artigas 1998) . The composition of HPLC eluant was as follows: 0.15 m NaH 2 PO 4 , 1.3 mm octyl sodium sulphate, 0.2 mm EDTA (pH 2.8 adjusted with phosphoric acid) plus 27% methanol. 5-HT was separated on a 3-mm ODS 2 column (7.5 cm Â 0.46 cm; Beckman, San Ramon, CA, USA) and detected amperometrically with a Hewlett Packard 1049 detector (oxidation potential 1 0.6 V). Retention time was 3.5±4 min. The absolute detection limit for 5-HT was 0.5±1.0 fmol/sample. Dialysate 5-HT values were calculated by reference to standard curves run daily. In some experiments, the samples of rats treated locally with apomorphine in the DR were analyzed with a slight modi®cation of the above HPLC method. Brie¯y, run time was increased to 45 min per sample to avoid the interferences produced by apomorphine and other minor peaks in the HPLC trace.
Extracellular recordings of DR 5-HT neurons
The rats were anaesthetized with chloral hydrate (400 mg/kg, i.p.). A tracheal cannula was inserted and a jugular vein catheter was placed for additional injections of anaesthetic and other drugs. The rats were placed in a David Kopf stereotaxic frame (DKI, Tujunga, CA, USA) and rectal temperature was maintained at 378C by means of an electric heating pad. After exposing the skull, a 4-mm burr hole was drilled in the midline over the DR. The sagital sinus was ligated, cut and re¯ected. Single unit extracellular recordings from DR neurons were made as previously described (Wang and Aghajanian 1982) . The recording electrode was an Omegadot single-barrel glass micropipette (List Biological Labs, Campbell, CA, USA) ®lled with a 2% solution of Pontamine sky blue in 0.5% sodium acetate. The impedance of the electrode (tip diameter 1±2 mm), measured in 0.9% NaCl at 135 Hz, was 2±6 mV. The electrode was placed in the midline 1 mm anterior to lambda and 4.5±6.0 mm ventral to the exposed tissue, according to the atlas Fig. 1 Effect of the administration of apomorphine and quinpirole on the 5-HT output in the dorsal raphe nucleus (a, c and e) and dorsal striatum (b, d and f ). The subcutaneous administration of apomorphine (Apo; 0.5, 1 and 3 mg/kg s.c.; injections marked by arrows) increased the 5-HT output in the dorsal raphe nucleus (a) and dorsal striatum (b). The administration of the selective DA D2-like agonist quinpirole (Quin, 0.5 mg/kg) enhanced the 5-HT output in the dorsal raphe nucleus (c) but not in dorsal striatum (d). The increase in 5-HT output produced by 3 mg/kg apomorphine in the dorsal raphe nucleus was potentiated by the administration of 0.3 mg/kg s.c. WAY 100635 (WAY). The administration of WAY 100635 alone increased signi®cantly the 5-HT output in the dorsal raphe nucleus but not in dorsal striatum (note the different scale in e and f ). Data are mean^SE of 5±8 rats/group. Control rats (open circles, n 5 in dorsal raphe nucleus and 6 in striatum) were injected with saline. See text for statistical analysis.
of Paxinos and Watson (1986) . The signal from the recording electrode was passed through a high-input impedance ampli®er, delivered to an audiomonitor and continuously monitored on an oscilloscope. Single neuronal spikes were discriminated in a custom-made unit, counted in an electronic rate counter, sent to a computer generating interspike time interval histograms and recorded on a pen chart recorder as spikes per 10 s. In experiments assessing the effects of i.v. administration of drugs, only one cell per rat was recorded. DR serotonergic cells were identi®ed by their long duration action potentials and a regular, slow (0.5±3 spikes/s) discharge rate. We administered the selective 5-HT1A receptor agonist 8-OH-DPAT at the end of the experiments to additionally con®rm the serotonergic nature of the recorded cells. A 5-mA cathodal current was passed through the recording electrode in order to leave a blue spot at the recording site. The brains were ®xed by intracardial perfusion with 4% formalin and frozen sections (50-mm thick) were stained with neutral red and examined microscopically for histological veri®cation of the recording site.
Pressure microinjection into the DR For the local administration of quinpirole, a thick-walled pipette with a calibrated inner diameter (Blaubrand; Intramark, Houston, TX, USA) was glued to a recording electrode, according to Akaoka et al. (1992) . The calibrated pipettes were ®lled with Dulbecco's buffered saline solution containing (in mm): NaCl 136.9, KCl 2.7, NaH 2 PO 4 8.1, KH 2 PO 4 1.5, MgCl 2 0.5 and CaCl 2 0.9 (pH 7.4), with or without quinpirole. Drug ejection was performed by applying pressure pulses (100±200 ms) with a solenoid-controlled pneumatic device (Picospritzer TM II, General Valve Corporation; Fair®eld, NJ, USA). The volume injected was measured by monitoring the movement of the¯uid in the calibrated pipette. In each rat we checked the sensitivity of the last recorded neuron to the i.v. administration of 8-OH-DPAT.
In situ hybridization histochemistry
Oligonucleotide probes complementary to the mRNA coding for the rat dopamine D 2 receptor (bases 1212±1245, Bunzow et al. 1988; Mengod et al. 1989) , the 5-HT transporter (bases 612±659, Blakely et al. 1991) and glutamic acid decarboxylase (GAD) (bases 1537±1590, Kobayashi et al. 1987) were used. Oligonucleotides were labelled at the 3 H end with terminal deoxynucleotidyltransferase (Boehringer Mannheim, Mannheim, Germany) and [ 32 P]a-dATP (3000 Ci/mmol; DuPont±NEN, Boston, MA, USA) to speci®c activities of 2±3 Â 104 Ci/mmol. The labelled probes were puri®ed with Qiaquick columns (Qiagen, Valencia, CA, USA).
Tissue treatment before hybridization was essentially as described (Vilaro Â et al. 1992) . For hybridization, labelled probes were diluted to a ®nal concentration of 2 Â 107 cpm/mL in a solution containing 50% formamide, 4 Â SSC (1 Â SSC: 150 mm NaCl, 15 mm sodium citrate), 1 Â Denhardt's solution (0.02% ®coll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin), 10% dextran sulphate, 1% sarkosyl, 20 mm phosphate buffer pH 7.0, 250 mg/mL yeast tRNA, 500 mg/mL salmon sperm DNA. Tissue sections (14 mm thick) were covered with 80 mL of hybridization solution, overlaid with Nesco®lm coverslips, and incubated overnight in humid boxes at 428C. Sections were washed four times (45 min each) in 600 mm NaCl, 20 mm Tris-HCl pH 7.5, 1 mm EDTA at 608C, dehydrated in graded ethanols and dried. Hybridized sections were dipped in liquid emulsion (LM1, Amersham) and exposed for 4 weeks for the 5-HT transporter mRNA, 5 weeks for the GAD mRNA and 7 weeks for the dopamine D 2 receptor mRNA.
Data treatment and statistics
The concentration of 5-HT in dialysates (mean^SE) is expressed as fmol/fraction and represented in ®gures as percentages of baseline (average of 3±4 predrug fractions). The statistical analysis was performed using one-or two-way analysis of variance (anova) for repeated measures of raw data (fmol/fraction) followed by Tukey's test where appropriate. We analysed the effect of the independent factor (treatment group), the repeated factor (time) and the interaction between them. The latter assessed whether the change in 5-HT over time differs between treatment groups (e.g. treated versus controls). Thus, a signi®cant p-value of the treatment or the time±treatment interaction indicates differences in the effects of two or more treatments on 5-HT output. Averaged values of Fig. 2 The administration of the DA D 1 receptor antagonist SCH 23390 (0.3 mg/kg s.c., ®rst arrow) antagonized the increase in 5-HT output produced by the administration of apomorphine (0.5 mg/kg s.c., second arrow) in the dorsal raphe nucleus (a) and striatum (b). Likewise, the DA D 2 receptor antagonist raclopride (1 mg/kg s.c., ®rst arrow) antagonized, though to a lesser extent than SCH 23390, the effect of apomorphine in the dorsal raphe nucleus. Note that the Y-axis scales are different in (a) and (b) due to the increase in 5-HT output elicited by the repeated injection procedure in two experimental groups in the dorsal raphe nucleus. Data are mean^SEM of 4±7 rats/group. See text for statistical analysis. post-treatment periods (100 min; fractions 6±10) have been used to examine the effects of DA receptor antagonists on the increase in 5-HT output produced by apomorphine. In these calculations, the data from fraction 5 (®rst post-treatment fraction) were omitted from the calculations due to the increase in 5-HT (Adell et al. 1997) produced by the two-injection procedure in the DR. In electrophysiological recordings, the individual ®ring rates during baseline and drug periods were averaged and computed using 1-min periods and compared using paired Student's t-tests. Statistical signi®cance has been set at the 95% con®dence level (two-tailed).
Results
Baseline 5-HT output Baseline dialysate 5-HT concentrations in presence of 1 mm citalopram were 35.3^1.9, 18.3^1.0 and 27.2^4.1 fmol/fraction in the DR, dorsal striatum and SN (n 104, 79 and 11, respectively). In absence of citalopram, the corresponding values in DR and striatum were 6.5^1.0 and 2.7^0.5 fmol/fraction (n 13 and 11, respectively). The dialysate 5-HT values in the DR were signi®cantly greater than in the striatum in presence of citalopram ( p , 0.00001, Tukey's test post anova).
Enhancement of the 5-HT release by systemic apomorphine and quinpirole
The administration of the non-selective DA receptor agonist apomorphine (0.5, 1 and 3 mg/kg s.c.) resulted in a stereotyped behaviour (mainly snif®ng, licking and grooming) and enhanced the 5-HT output in the DR (F 15 , 270 6.81, p , 0.0001 time effect; F 45 , 270 1.69, p , 0.006 time± dose interaction; Fig. 1a ) and dorsal striatum (F 3,26 3.52, p , 0.03 dose effect; F 15 , 390 4.12, p , 0.0001 time effect; Fig. 1b) . Where the lower dose was used, the maximal elevation of the striatal 5-HT output occurred soon after administration (40 min). Higher doses (1 and 3 mg/kg s.c.) elicited a more persistent elevation, with the maximal increase occurring 2 h after administration (Fig. 1b) . In the DR, the differences in 5-HT output at the three doses used were more conspicuous than in striatum and maximal elevations occurred at 40±60 min postadministration. Beyond this time point, the 5-HT output declined rapidly at 0.5 mg/kg but remained elevated until Fig. 3 (a and b) The perfusion of apomorphine (10, 100 and 300 mM) in the dorsal raphe nucleus of rats bearing two dialysis probes did not alter the 5-HT output in the dorsal striatum and reduced it in the dorsal raphe nucleus at 300 mM (®lled circles, n 5). Control rats (open circles, n 7 in dorsal raphe nucleus, n 5 in striatum) were perfused with arti®cial CSF throughout the experiment. (c, d) The perfusion of quinpirole (QUIN; 10, 100 and 300 mM) in the DR of rats bearing two dialysis probes did not alter the 5-HT output in the DR or dorsal striatum (®lled circles, n 10 in DR; n 6 in striatum). Control rats (open circles, n 7 in DR, n 5 in striatum) were perfused with arti®cial CSF throughout the experiment. The lower number of rats in striatum is due to sample lost during the HPLC analysis.
the end of the experiment (4 h postadministration) in the rats treated with 3 mg/kg apomorphine.
To examine whether the presence of citalopram interfered the effects of apomorphine, a group of rats was treated with this agent but in this case the dialysis probes were perfused with an arti®cial CSF devoid of citalopram. The administration of 0.5 mg/kg apomorphine (n 6) elevated signi®cantly the striatal 5-HT output with respect to controls (maximal increase 192^20% of controls; n 5) (F 15 , 135 2.02, p , 0.02 time effect; F 15 , 135 2.97, p , 0.0004 time±dose interaction). The 5-HT output in the DR was also increased by apomorphine (1 and 3 mg/kg) in absence of citalopram, to a maximum of 150^16% of baseline (F 15 , 165 2.07, p , 0.015 time effect).
The administration of the DA D2-like receptor agonist quinpirole (0.5 mg/kg s.c.) also increased signi®cantly the 5-HT output in the DR (F 15 , 105 3.15, p , 0.0003; Fig. 1c ). However, it failed to induce a similar increase in striatum (Fig. 1d ). Given this difference between the effects of apomorphine and quinpirole in striatum, we examined whether DA D 1 receptors could be involved in the 5-HTenhancing action of apomorphine. Groups of rats were administered with saline or the selective DA D 1 receptor antagonist SCH 23390 (0.3 mg/kg s.c.) 20 min before apomorphine. SCH 23390 signi®cantly attenuated the increase in DR 5-HT output produced by 0.5 mg/kg s.c. apomorphine. The average post-treatment values for the saline 1 apomorphine and SCH 23390 1 apomorphine groups were, respectively, 141^11% (n 5) and 87^13% (n 4) ( p , 0.02, Student's t-test). Pretreatment with raclopride (1 mg/kg s.c., 20 min before apomorphine) also attenuated the apomorphine-induced increase of the 5-HT output in DR (Fig. 2) , although the antagonism exerted by this dose was less marked than that of SCH 23390 and was only marginally signi®cant (141^11 versus 113^3%, n 5 and 4, respectively; p 0.06, Student's t-test). In the dorsal striatum, pretreatment with SCH 23390 (0.3 mg/kg s.c.) 20 min before apomorphine 0.5 mg/kg also attenuated its effects on the 5-HT output (saline 1 apomorphine, 125^7% (n 7) versus SCH 23390 1 apomorphine 101^7% (n 7), p , 0.04, Student's t-test) (Fig. 2) . The pretreatment with SCH 23390 and raclopride abolished the apomorphine-induced stereotypies.
Interaction with 5-HT 1A autoreceptors
The effect of drugs that increase the synaptic availability of 5-HT in the DR is limited by a negative feedback mechanism involving raphe 5-HT 1A autoreceptors (Artigas et al. 1996) . We therefore examined whether 5-HT 1A receptors restrained the apomorphine-induced increase in 5-HT output. The administration of the selective 5-HT 1A receptor antagonist WAY 100635 (0.3 mg/kg s.c.) markedly enhanced the 5-HT output in the DR with respect to control rats injected with saline (F 1,9 4.79, p , 0.06 dose effect; F 15 , 135 5.03, p , 0.00001 time effect; F 15 , 135 5.75, p , 0.00001 time±dose interaction; Fig. 1e ). The 5-HT output rose to 300% of baseline and declined slowly thereafter. In contrast, WAY 100635 (0.3 mg/kg s.c.) did not signi®cantly alter the 5-HT output in striatum (Fig. 1f ) . The administration of WAY 100635 0.3 mg/kg s.c. in combination with apomorphine 3 mg/kg s.c. increased the 5-HT output signi®cantly more than apomorphine alone (F 15 , 135 8.12, p , 0.00001 time effect; F 15 , 135 5.99, p , 0.00001 time±treatment interaction; Fig. 1e ). This effect was not merely additive, since the combined treatment elevated the 5-HT output to < 550% of baseline. In dorsal striatum, the treatment with WAY 100635 0.3 mg/kg s.c. and apomorphine 3 mg/kg s.c. increased the 5-HT output comparably to apomorphine alone (Fig. 1f) .
Effects of the local application of apomorphine and quinpirole in the DR In rats implanted with two probes, the perfusion of apomorphine in the DR (10, 100 and 300 mm, four fractions each) reduced the 5-HT output at the higher concentration used (F 15 , 150 2.6, p , 0.002 time effect; F 15 , 150 1.58, p 0.083 time±treatment interaction Fig. 3a) . Apomorphine infusion in the DR did not signi®cantly alter the 5-HT output in dorsal striatum (Fig. 3b) . The perfusion of quinpirole (10, 100 and 300 mm, four fractions each; n 10) in the DR did not affect signi®cantly the 5-HT output in either region (Figs 3c and d) .
In a previous report, the infusion of apomorphine (10±100 mm) induced a transient increase of the 5-HT output in the DR (Ferre Â and Artigas 1993) . To examine the reasons of this discrepancy, we conducted two additional experiments in which apomorphine (100 mm) was infused in the DR using two slightly different positions of the probes, i.e. aimed at the centre of the DR and in a slightly more lateral coordinate, to sample the lateral wings of the DR, as described in Ferre Â et al. (1994) . Apomorphine infusion did not signi®cantly increase the 5-HT output in either location (n 4 rats/group; data not shown).
Single unit recordings: effects of the administration of dopaminergic agents on serotonergic cell ®ring The administration of saline did not affect the ®ring rate of DR 5-HT neurons. The non-selective DA receptor agonist apomorphine (50±400 mg/kg i.v.) increased the ®ring rate in six out of the nine neurons tested. There was little difference between the effects of low and high doses of apomorphine (Fig. 4a) . Paired Student's t-test revealed a signi®cant difference between the baseline ®ring rate and that after the administration of 100 mg/kg ( p , 0.008, n 5) or 200 mg/kg ( p , 0.001, n 6). Irrespectively of the dose at which maximal effect was attained, this was signi®cantly different from baseline ( p , 0.002, n 6). Two other neurons were inhibited and one remained unaffected by the i.v. administration of apomorphine. When considering all 5-HT neurons, the effect was marginally signi®cant ( p 0.10). The further treatment with the selective 5-HT 1A receptor agonist 8-OH-DPAT (0.5±6 mg/kg) suppressed the ®ring activity in all units tested. The DA D 2 receptor antagonist raclopride (125 mg/kg i.v.) slightly (2 19%) reduced the ®ring rate of DR 5-HT neurons, although this change was not signi®cant and, injected 4 min before, prevented the increase in ®ring rate induced by cumulative doses of apomorphine (100±600 mg/kg i.v.; n 4) (Fig. 4b) . Likewise, the DA D 1 receptor antagonist SCH 23390 (400 mg/kg i.v) non-signi®cantly reduced serotonergic ®ring rate (2 20%) and, injected 4 min before, it also antagonized the increase in cell ®ring elicited by the injection of apomorphine (100±400 mg/kg i.v.; n 4; Fig. 4b ).
The i.v. administration of the DA D2-like agonist quinpirole also enhanced the ®ring rate of 5-HT neurons of the DR, although this effect was somewhat less marked than that of apomorphine (Figs 4c and d) . At 80 mg/kg, quinpirole signi®cantly increased the ®ring rate of 5-HT cells compared to baseline ( p , 0.025, n 5) whereas at a higher dose (160 mg/kg) the effect was marginally signi®cant ( p 0.095, n 6).
Micropressure injection of Dulbecco's solution (used as vehicle) did not alter the ®ring rate of 5-HT neurons. We used veratridine as a positive control to depolarize 5-HT neurons. The injection of veratridine (0.4±3.2 pmol) increased the ®ring rate of all 5-HT neurons tested (n 5; maximal effect 1277% at 0.8 pmol in one neuron; data not shown). The administration of quinpirole by micropressure injection affected 5-HT neurons in a bimodal manner. In 16 cells of seven different rats, quinpirole (0.2±8 pmol) markedly inhibited the serotonergic ®ring rate (Fig. 4e) . The mean inhibition was 53% (maximal 85% at 8 pmol injected; average of four rats). However, in ®ve neurons of the same rats, the application of quinpirole was without effect up to 6 pmol (Fig. 4f) . Neither neuron was excited by the application of quinpirole. Both quinpirole-sensitive and -insensitive 5-HT neurons were found randomly in descents along the midline. At the end of the experiments in each rat, we administered 8-OH-DPAT to con®rm the serotonergic nature of the last neuron recorded. In situ hybridization studies Rat brain coronal sections at different anterior±posterior levels of the DR were treated as described (see Methods) and hybridized with probes complementary to the mRNA encoding the DA D 2 receptor. 5-HT cells in adjacent sections were labelled with a 35 S-oligonucleotide probe directed against the 5-HT transporter. Figure 5 shows in situ hybridization autoradiograms of the DR at two different magni®cations (Figs 5a±b, c±d) . A large number of 5-HT neurons were labelled by the oligonucleotide probe directed against the 5-HT transporter (Figs 5a and c) . However, very few cells showed the presence of the DA D 2 transcript (Figs 5b and d) . The substantia nigra pars compacta showed abundant dopaminergic neurons that were labelled by the same oligonucleotide probe (Fig. 5e) . In the DR, very few neurons (marked by arrows) appeared to be labelled by both oligonucleotide probes in adjacent sections (Figs 5a±d).
In the PAG adjacent to the DR there was an abundance of cells containing the transcript for the DA D 2 receptor (Fig. 6a) . This area was also very rich in GABAergic neurons, as labelled by the transcript for GAD, the GABAsynthesizing enzyme (Fig. 6b) (unlike in the previous ®gure, these sections are not adjacent).
Dual probe experiments in SN and DR
The missmatch between the local and systemic effects of apomorphine and quinpirole suggested that the dopaminergic receptors responsible for the systemic effect of these drugs were not located in the DR. Given the presence of a large density of DA D 2 receptors in the SN and the existence of anatomical and functional relationships between the SN and the DR (see Introduction) we performed dual probe experiments to examine whether dopaminergic receptors in the SN could be involved in the effects of systemic apomorphine administration. Control rats perfused with arti®cial CSF for the whole experiments did not show any change in the 5-HT output in either region. The infusion of TTX (10 mm) in the SN markedly reduced the 5-HT release in this structure compared to controls (F 9,90 8.24 p , 0.00001 time effect; F 9,90 8.56 p , 0.00001 time± treatment interaction) and evoked a parallel increase in the DR (F 9,63 3.14, p , 0.005, time±treatment interaction) (Figs 7a and b) . Likewise, the application of apomorphine (10±100 mm) in the SN signi®cantly enhanced the 5-HT in the DR compared with controls (F 9,72 2.88, p , 0.005, time±treatment interaction; Fig. 8 ). In this case, the 5-HT concentration in samples of SN during the application of apomorphine could not be determined due to the presence of interfering peaks in the HPLC trace.
Discussion
The present study examined the effects of dopaminergic agents on the activity of DR 5-HT neurons using two In dual probe experiments, the application of 100 mM apomorphine (X) in the SN signi®cantly raised the 5-HT output in the DR. The 5-HT content in samples from SN could not be determined due to interfering peaks in the HPLC trace (likely apomorphine impurities). Data are mean^SE of six rats. Controls (W, n 4) were perfused with arti®cial CSF. See Results for statistical details. different techniques, in vivo microdialysis in freely moving rats and single unit recordings in the DR of anaesthetized rats. Overall, the results support a facilitatory action of DA D 1 and D 2 receptors on the activity of DR 5-HT neurons and of the 5-HT release in the DR. However, the single activation of DA D 2 receptors is not suf®cient to increase the striatal 5-HT release.
In agreement with previous data (Ferre Â et al. 1994) , the systemic administration of apomorphine enhanced the 5-HT output in the DR at all doses examined. This effect appears to involve DA D 1 and D 2 receptors, since it was fully antagonized by SCH 23390 and partly by raclopride. The involvement of DA D 2 receptors in the control of DR 5-HT output is also supported by the increase produced by quinpirole. The fact that SCH 23390 reduced 5-HT levels to below baseline may be indicative of a tonic control of 5-HT release in the DR by DA D 1 receptors.
Also, as previously observed at 0.5 mg/kg (Mendlin et al. 1998) , apomorphine increased the 5-HT output in the dorsal striatum at this and higher doses. The antagonism of this effect by SCH 23390 supports the involvement of DA D 1 receptors. However, Mendlin et al. (1998) reported that systemic raclopride antagonized the increase in striatal 5-HT output produced by apomorphine, an observation that appears to be at variance with the unchanged striatal 5-HT output after quinpirole administration observed in the present study. A higher quinpirole dose (1 mg/kg s.c.) was also without effect in striatum and increased the 5-HT output in the DR (Martõ Ân-Ruiz and Artigas, unpublished observations). Moreover, the local application of 10 mm (Ferre Â et al. 1994) or higher (up to 1 mm) quinpirole concentrations (Abella Ân et al. 2000b) in dorsal striatum did not change the local 5-HT output. These observations raise doubts about the role of DA D 2 receptors in the control of the striatal 5-HT output. Thus, the present microdialysis experiments suggest that both DA D 1 and D 2 receptors are involved in the stimulatory effect of apomorphine on the 5-HT output in the DR but only the former appear to control the striatal 5-HT output.
In addition to increasing DR 5-HT output, apomorphine and quinpirole enhanced the ®ring rate of DR 5-HT neurons. Data from in vivo microdialysis and single unit recordings are not directly comparable due to the different routes of drug administration, the use of anaesthetized rats in single unit experiments and the distinct time scale of both techniques. However, the 5-HT release in the DR is sensitive to the propagation of nerve impulses, as it is reduced by TTX and 5-HT 1A agonists (Matos et al. 1996; Casanovas et al. 1997) and increased by depolarizing agents such as KCl or veratridine (Casanovas et al. unpublished observations) . Thus, it is conceivable that the increase in DR 5-HT output produced by apomorphine results from a higher discharge rate of 5-HT neurons observed in single unit experiments. In agreement, Fornal et al. (1996a) observed an increase in serotonergic ®ring rate after the administration of apomorphine to awake cats.
The change in 5-HT cell ®ring elicited by dopaminergic agents was moderate (^20±35%). This hindered the ®nding of a clear dose-effect relationship, as the effects of the lower doses employed were nearly maximal. SCH 23390 and raclopride signi®cantly antagonized the enhancing effect of apomorphine. Thus, the facilitation of serotonergic activity by apomorphine appears to involve DA D 1 and D 2 receptors, as also observed in microdialysis experiments performed in the DR (see above). DA D 2 (but not DA D 1 ) receptors are present in a moderate density in the DR (Bouthenet et al. 1987; Palacios and Pazos 1987) . This raised the possibility that they mediate the facilitatory effects of apomorphine and quinpirole on 5-HT neurons. However, the local application of these dopaminergic agonists in the DR in a wide range of concentrations did not increase the 5-HT output in this area or dorsal striatum in dual probe experiments. This is in contrast with previous observations from this laboratory showing that the application of apomorphine and quinpirole in the DR induced a moderate and transient increase in the local 5-HT output (Ferre Â and Artigas 1993) . This discrepancy does not appear to be accountable by methodological factors such as probe type and location, perfusion¯uid, analytical method, etc. Similar procedures were used in past and present studies, with the exception that the rats used herein were gently manipulated before experiments to reduce the effects of the stress/arousal associated to handling and injection on the raphe 5-HT output (Adell et al. 1997) . In the present study, this increase was only evident in rats injected twice (e.g. antagonist experiments). It is thus possible that a distinct behavioural state of rats may play a role in this discrepancy. Interestingly, Mendlin et al. (1999) noted that raclopride attenuated the striatal 5-HT increase induced by behavioural activation but did not alter the basal 5-HT output in this area, as previously observed (Ferre Â et al. 1994) . On the other hand, the blockade of postsynaptic 5-HT receptors attenuated the increase of the DA output in activated but not basal conditions (de Deurwaerde Áre and Spampinato 1999). These observations suggest a complex interaction between DA and 5-HT systems in which phasic stimuli may play an important role.
The dorsal striatum is exclusively innervated by 5-HT neurons from the DR (Azmitia and Segal 1978) . 5-HT 1A receptor antagonists augment the effects of drugs that increase extracellular 5-HT in the DR by preventing a negative feedback mediated by 5-HT 1A autoreceptors (Artigas et al. 1996) . The WAY 100635-induced potentiation of the effect of apomorphine on the DR 5-HT output suggests that 5-HT 1A autoreceptors also limit the effect of apomorphine on the DR output. This agrees in part with the conclusion from previous experiments showing that the 5-HT 1A receptor antagonist WAY 100135 reversed a moderate inhibition in striatal 5-HT output produced by apomorphine (Ferre Â et al. 1994) . Although the net effect of apomorphine on striatal 5-HT output differed markedly in both studies, the fact that apomorphine 1 5-HT 1A antagonist combinations elevated 5-HT more than apomorphine alone in one or other area supports the notion that apomorphine indirectly increases the tone on 5-HT 1A autoreceptors.
The increase in DR 5-HT output elicited by WAY 100635 alone is consistent with the increase in serotonergic ®ring rate elicited by this agent in awake cats (Fornal et al. 1996b) and in midbrain slices containing the DR (Corradetti et al. 1996) although no such effect was observed in anaesthetized rats (Gartside et al. 1995) . WAY 100635 might antagonize a tonic self-inhibition of the activity of 5-HT neurons, this leading to an increased release in the DR. However, we cannot discard that WAY 100635 reversed a citalopraminduced inhibition of 5-HT release in the DR given the presence of the SSRI in the perfusion¯uid. WAY 100635 administration markedly potentiated the increase in 5-HT output produced by a larger (50 mm) citalopram concentration that activates raphe 5-HT 1A autoreceptors (Romero and Artigas 1997 ). Yet, it is unclear whether 1 mm citalopram, which elicits a partial blockade of the 5-HT reuptake (in vivo EC 50 1.0 mm; Herva Âs et al. 2000) can activate suf®ciently 5-HT 1A autoreceptors as to attenuate the local 5-HT release. Contrary to the DR, WAY 100635 did not elevate the striatal 5-HT output when given alone, as previously observed (Romero and Artigas 1997) , nor did it potentiate the effect of apomorphine in striatum (Mendlin et al. 1998 ; this study) which suggests a distinct sensitivity of the 5-HT release in both areas to WAY 100635 administration.
Quinpirole excited 5-HT neurons when administered systemically but not when applied in the DR. On the contrary, micropressure injection of quinpirole inhibited more than 70% of the neurons tested. Vehicle applications were without effect and veratridine dramatically increased the ®ring rate of 5-HT neurons, which validates the technique used. The local effect of quinpirole would be consistent with the inhibitory responses elicited by DA D 2 receptor stimulation (Vallar and Meldolesi 1991) . However, few serotonergic neurons expressed this receptor subtype in the DR, which precludes their involvement in the local effects of quinpirole. Recently, dopamine was found to depolarize 5-HT neurons in vitro by an action on DA D 2 receptors (Haj-Dahmane and Shen 2000) which further complicates the understanding of the DA25-HT interaction in the DR. It is unlikely that quinpirole-sensitive neurons were dopaminergic because of their ®ring characteristics, response to 8-OH-DPAT (when assessed) and low number in the DR (Ho Èkfelt et al. 1976; Geffard et al. 1987; Kale Ân et al. 1988) . Moreover, all recorded neurons were found in descents along the midline, containing dopaminergic ®bres but few DA cell bodies (Geffard et al. 1987) . It is possible that the inhibition of 5-HT neurons by quinpirole results from a non-speci®c effect at the local doses used. Quinpirole and 8-OH-DPAT display common behavioural actions (Ahlenius and Larsson 1997 ). Yet, despite the high density of 5-HT 1A receptors in the DR and its inhibitory role, it is unlikely that quinpirole inhibits 5-HT neurons by activation of 5-HT 1A autoreceptors since quinpirole displays low af®nity for 5-HT 1A receptors (Toll et al. 1998) and these are present in all 5-HT DR neurons (Sotelo et al. 1990 ) whereas quinpirole only inhibited 16 of the 21 neurons tested.
The scarcity of 5-HT neurons containing the DA D 2 receptor transcript and the fact that systemic quinpirole and apomorphine increased 5-HT cell ®ring and release suggests that the facilitation of serotonergic transmission produced by these agents is indirect, possibly through dopaminergic receptors in areas projecting to the DR. Several such areas exist in the midbrain that exhibit a moderate or high density of DA D 2 receptors, such as the SN, the ventral tegmental area and the lateral habenula (Bouthenet et al. 1987; Palacios and Pazos 1987) . In addition, the PAG, in close vicinity to the DR, contains dense plexuses of dopaminergic ®bres (Peyron et al. 1995) and a large density of DA D 2 receptors (Bouthenet et al. 1987) as well as GABAergic afferents to the DR (Gervasoni et al. 2000) .
The activity of DR 5-HT neurons is tonically inhibited by GABA during periods of low behavioural activity, such as the light period in rats ± present experimental conditions ± (Nitz and Siegel 1997; Gervasoni et al. 2000) . The activation of inhibitory receptors such as m-opioid or GABA B located on these GABAergic afferents disinhibits 5-HT neurons and increases the 5-HT release in the DR (Tao and Auerbach 1994; Jolas and Aghajanian 1997; Abella Ân et al. 2000a) . The presence of GAD and DA D 2 transcripts in the PAG suggests that such a mechanism might participate in the increase in cell ®ring and 5-HT release elicited by apomorphine and quinpirole. It remains to be established (e.g. by using double in situ hybridization) whether both transcripts colocalize. Also, further work is needed to examine this possibility at a functional level using techniques other than dual probe microdialysis due to the proximity of the PAG and the DR.
In addition, DA receptors in the SN could be involved in the facilitatory effects of apomorphine and quinpirole on 5-HT neurons. The electrical stimulation of the SN suppressed the ®ring activity of DR 5-HT neurons (Stern et al. 1981) and somatodendritic DA receptors in the SN were postulated to regulate the activity of the raphe-striatal pathway (He Âry et al. 1980) . The dual-probe experiments conducted in the present study support the notion that the dopaminergic receptors in the SN may be involved in the effects of apomorphine on DR 5-HT neurons. Thus, the suppression of nerve impulses in the SN by TTX increased the 5-HT output in the DR, which supports an inhibitory role of the SN on DR activity in accordance with previous electrophysiological evidence (Stern et al. 1981) . Since the 5-HT output in the DR is markedly reduced by the local application of TTX (Matos et al. 1996) it is obvious that TTX diffusion to the DR cannot account for the 5-HT increase observed. The limited spatial resolution of dialysis probes (1.5-mm tip size) does not enable to conclude which part of the SN was involved in this effect but, conceivably, TTX suppressed the nigral GABAergic output to the midbrain (Chevalier and Deniau 1990) , thus disinhibiting 5-HT neurons.
Furthermore, the activation of DA receptors in the SN by apomorphine enhanced the 5-HT output in the DR. Given the greater increase in DR output produced by apomorphine (versus quinpirole) we preferred to use the former, despite its lack of selectivity for DA D 1 and D 2 receptors. Indeed, the maximal effect size in the DR was moderate (,25%). However, apomorphine was applied unilaterally, thus affecting half of the nigral neurons putatively affected by systemic administration. These results are in agreement with the observation that the application of l-DOPA by reverse dialysis in the SN of freely moving rats increased the local 5-HT output and that in striatum (Thorre Â et al. 1998 ) which also appears to support a facilitatory action of nigral DA on the activity of the raphe-striatal pathway. Given the nonselective actions of apomorphine and the presence of DA D 1 receptors in the SN (Levey et al. 1993 ) both receptor subtypes might be involved in apomorphine effects.
In summary, the present results provide further evidence of a complex control of the serotonergic activity by dopaminergic transmission. Both DA D 2 and D 1 receptors are involved in the control of serotonergic activity and 5-HT release in the DR, whereas only the latter appear to mediate the facilitatory effects of apomorphine in the dorsal striatum. Based on the mismatch between the effects of local and systemic applications of drugs (also supported by mRNA data) we propose that dopaminergic receptors outside the DR control the activity of serotonergic neurons. A subpopulation of these receptors appears to be located in the SN, although other brain areas cannot be discarded and in particular the PAG, rich in DA D 2 receptor and GAD transcripts.
